ambossIconambossIcon

Nephritic syndrome

Last updated: September 26, 2024

Summarytoggle arrow icon

Nephritic syndrome is characterized by glomerular inflammation that causes glomerular hematuria (e.g., with red blood cell casts), sterile pyuria, and mild to moderate proteinuria leading to hypertension, oliguria, and/or fluid retention with mild to moderate peripheral edema. This syndrome can be caused by a variety of conditions including autoimmune, hereditary, and infectious diseases leading to glomerulonephritis. Nephritic diseases can manifest with varying degrees of severity, ranging from asymptomatic hematuria to systemic involvement and end-stage renal disease (ESRD), as in rapidly progressive glomerulonephritis (RPGN). Diagnosis of the underlying disease is often based on presentation and laboratory values, although renal biopsy is usually required for diagnostic confirmation. Various forms of microscopy are frequently used to distinguish features and assist with diagnosis. These include light microscopy (LM), immunofluorescence microscopy (IM), and electron microscopy (EM).

See “Glomerular diseases” for more information on the pathophysiology of glomerulonephritis and differentiating nephritic and nephrotic syndrome.

Icon of a lock

Register or log in , in order to read the full article.

Definitionstoggle arrow icon

NephrItic syndrome indicates glomerular Inflammation.

Icon of a lock

Register or log in , in order to read the full article.

Etiologytoggle arrow icon

Glomerulonephritis [1][4]

Glomerulonephritis was traditionally classified according to histopathological patterns but is now more commonly classified by etiology. [4]

Pulmonary-renal syndromes [5]

Conditions that can simultaneously involve the kidneys and lungs are classified as pulmonary-renal syndromes; causes include:

Icon of a lock

Register or log in , in order to read the full article.

Pathophysiologytoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Clinical featurestoggle arrow icon

Icon of a lock

Register or log in , in order to read the full article.

Managementtoggle arrow icon

Approach [4][6]

Nephritic syndrome is diagnosed based on clinical presentation and the presence of nephritic sediment on urinalysis.

  • Consult nephrology and other specialists as needed (e.g., rheumatologist, infectious disease specialist).
  • Perform a thorough clinical evaluation, and obtain guided diagnostics to determine the underlying cause.
  • Renal biopsy is usually required for diagnostic confirmation.
  • Management is disease-specific; see “Diseases associated with nephritic syndrome.”
  • Start general management for complications (e.g., supportive care for AKI).

Suspect RPGN in patients with nephritic sediment who have rapidly rising serum creatinine levels, and start diagnostic testing immediately. A renal biopsy is vital for quick diagnosis and initiation of appropriate treatment.

Laboratory studies [4][6][7]

Glomerular hematuria is a typical finding in nephritic syndrome and is characterized by acanthocytes, RBC casts, and mild to moderate proteinuria. Nonglomerular hematuria is characterized by bright red or pink urine, normal RBC morphology, the absence of RBC casts, and the possible occurrence of blood clots.

Additional studies [4][6][7]

Obtain additional studies to establish the cause of nephritic syndrome.

Low serum C3 levels are seen in poststreptococcal glomerulonephritis, lupus nephritis, and membrane proliferative glomerulonephritis.

Renal biopsy [9]

A renal biopsy is usually required to determine the underlying cause of nephritic syndrome. In some cases (e.g., in infection-related glomerulonephritis or hereditary glomerulonephritis), renal biopsy may be deferred if the diagnosis is clear based on laboratory studies. [4][6][9]

Management of complications [9][9]

Icon of a lock

Register or log in , in order to read the full article.

Rapidly progressive glomerulonephritistoggle arrow icon

Red flags for RPGN [3]

Management [3]

Prognosis [3]

  • Full recovery of renal function occurs in most patients who receive early treatment.
  • Without proper treatment, the prognosis is unfavorable with rapid progression to ESRD and high mortality.

In RPGN, renal function is lost within 3 months of clinical onset. [3]

Icon of a lock

Register or log in , in order to read the full article.

Differential diagnosestoggle arrow icon

The differential diagnoses listed here are not exhaustive.

Icon of a lock

Register or log in , in order to read the full article.

Diseases associated with nephritic syndrometoggle arrow icon

Diseases commonly associated with nephritic syndrome and their characteristics are summarized below.

Icon of a lock

Register or log in , in order to read the full article.

Anti-GBM diseasetoggle arrow icon

Overview of anti-GBM disease [1][4]
Anti-GBM disease (Goodpasture disease)
Epidemiology
  • Two peaks of occurrence [12]
Pathophysiology
Distinguishing features
Laboratory studies
Renal biopsy IM
EM
  • Breaks in the GBM
  • No electron-dense deposits
  • Necrosis
Management
IM = immunofluorescent microscopy, EM = electron microscopy
Icon of a lock

Register or log in , in order to read the full article.

Immune complex-mediated GNtoggle arrow icon

Overview of immune complex-mediated glomerulonephritis [1][4]
Poststreptococcal glomerulonephritis IgA nephropathy (Berger disease) Lupus nephritis
Epidemiology
  • Usually affects children 3–12 years of age and individuals > 60 years of age [14][15]
  • Common: found in up to 50% of individuals with SLE at presentation [18]
Pathophysiology
Distinguishing features
Laboratory studies
Renal biopsy LM
  • Glomeruli appear enlarged and hypercellular.
IM
EM
Management
LM = light microscopy, IM = immunofluorescent microscopy, EM = electron microscopy

Icon of a lock

Register or log in , in order to read the full article.

ANCA-associated GNtoggle arrow icon

Overview of ANCA-associated glomerulonephritis (pauci-immune glomerulonephritis) [1][4][10]
Granulomatosis with polyangiitis Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) Microscopic polyangiitis
Epidemiology
  • >
  • Most frequent: 40–60 years of age [21]
Pathophysiology
Distinguishing features
Laboratory findings
Biopsy findings IM
EM
  • Usually no electron-dense deposits
Management
LM = light microscopy, IM = immunofluorescent microscopy, EM = electron microscopy
Icon of a lock

Register or log in , in order to read the full article.

Start your trial, and get 5 days of unlimited access to over 1,100 medical articles and 5,000 USMLE and NBME exam-style questions.
disclaimer Evidence-based content, created and peer-reviewed by physicians. Read the disclaimer